1. Bernstein L, Burns C, Sailer-Hammons M, Kurtz A, Rohr F. Multiclinic Observations on the Simplified Diet in PKU. J Clin Nutr Metab. 2017; 2017:1-5. doi:10.1155/2017/4083293
2. Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009;38(2):58-64.
3. Eijgelshoven I, Demirdas S, Smith TA, Van Loon JM, Latour S, Bosch AM. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab Rep. 2013; 109(3):237-42.
doi:10.1016/j.ymgme.2013.05.003
4. Goodarzi E, Ghaderi E, Khazaei S, Alikhani A, Ghavi S, Mansori K, et al. The prevalence of transient and permanent congenital hypothyroidism in infants of Kurdistan Province, Iran (2006-2014). Int J Pediatr. 2017; 5(2):4309-18. doi:
10.22038/ijp.2016.7902
5. Etemad K, Khazaei Z, Pordanjani SR, Shahsavand M, Ajam F, Riahi S-M, et al. Evaluation of the therapeutic interventions effects on body growth pattern of infants with congenital hypothyroidism. Biomed Res Ther. 2018; 5(4):2194-207.
doi:10.15419/bmrat.v5i4.433
6. Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, et al. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology. 2005; 236(2):630-6.
doi:10.1148/radiol.2362040611
7. Moradi K, Alibakhshi R. High risk of birth defects with PKU in Mast-e Ali village, Kermanshah province. J Kermanshah Univ Med Sci. 2014; 18(1):62-5.
8. Dos Santos LL, De Castro Magalhães M, De Oliveira Reis A, Starling ALP, Januário JN, da Fonseca CG, et al. Frequencies of phenylalanine hydroxylase mutations I65T, R252W, R261Q, R261X, IVS10nt11, V388M, R408W, Y414C, and IVS12nt1 in Minas Gerais, Brazil. Genet Mol Res. 2006; 5(1):16-23. PMID:16755493
9. Motamedi N, Goodarzi E, Pordanjani SR, Valizadeh R, Moradi Y, Sohrabivafa M, et al. Incidence of phenylketonuria in Lorestan province, West of Iran (2006-2016). Int J Pediatr. 2017; 5(40):4713-21. doi:10.22038/ijp.2017.21094.1770
10. Sipe NG, Dale P. Challenges in using geographic information systems (GIS) to understand and control malaria in Indonesia. Malar J. 2003; 2(1):36-44.
doi:10.1186/1475-2875-2-36
11. Seif A, Rashidi M, Rozbahani R, Daheshti N, Poursafa P. GIS application in medical researches a solution for prevention from disease. J Esfahan Univ Med Sci. 2011;29(164):1-10.
12. Tanser FC, Le Sueur D. The application of geographical information systems to important public health problems in Africa. Int J Health Geogr. 2002; 1(1):4-13.
doi:10.1186/1476-072X-1-4
13. Hassan A, Kenawy M, Kamal H, Abdel Sattar A, Sowilem M. GIS-based prediction of malaria risk in Egypt. East Mediterr Health J. 2003; 9 (4), 548-558.
14. Boulos MK, Roudsari AV, Carson ER. Health geomatics: an enabling suite of technologies in health and healthcare. J Biomed Inform. 2001; 34(3):195-219.
doi:10.1006/jbin.2001.1015
15. Magruder C, Burke M, Hann NE, Ludovic JA. Using information technology to improve the public health system. J Public Health Manag Pract. 2005; 11(2):123-30.
16. Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in Southern Iran. Iran J Med Sci. 2010; 35(2):137.
17. Badiee S, Morovatdar N, Hossini SMR, Norouzi F, Mina T. Epidemiological and clinical study of phenylketonouria (PKU) disease in Khorasan Province; Northeast Iran. Med J Mashhad Univ Med Sci. 2014; 57(3):571-8.
18. Madden M. Phenylketonuria: Defects in amino acid metabolism. Mol Med (SCJMM). 2004;5:57-61.
19. Kabiri M. A Report on the Incidence of phenylketonuria. Acta Medica Iranica. 1982;24(3-4):107-13.
20. Depatement G. Center of Noncommunicable Disease. Prevention and Control of Phenylketonuria Guideline. 2011:4-5.
21. Moradi P, Sari-Sarraf B, Khamnian Z, Dolatkhah R, Hadi S, Ghafari D, et al. Distribution Occurrence of Phenylketonuria in the World: A Systematic Review and Meta-Analysis. Depiction Health. 2016;6(4):1-12.
22. Koochmeshgi J, Bagheri A, Hosseini-Mazinani S. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J Inherit Metab Dis. 2002; 25(1):80-1. doi:10.1023/A:1015154321142
23. Pangkanon S CW, Janejai N, Boonwanich W, Chaisomchit S. Detection of phenylketonuria by the newborn screening program in Thailand. Southeast Asian J Trop Med Public Health. 2009; 40(3):525-9. PMID:19842439
24. Senemar SA, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009; 38(2):58-64.